Codiak BioSciences logo
Codiak BioSciences CDAK
$ 0.06 -55.98%

Quarterly report 2022-Q3
added 11-03-2022

report update icon

Codiak BioSciences Financial Statements 2011-2024 | CDAK

Annual Financial Statements Codiak BioSciences

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

240 M 444 M - - - - - - - - -

Shares

21.8 M 18.6 M - - - - - - - - -

Historical Prices

11.1 32.3 - - - - - - - - -

Net Income

-37.2 M -91.7 M -78 M -44.5 M - - - - - - -

Revenue

22.9 M 2.92 M 388 K - - - - - - - -

Cost of Revenue

- - - - - - - - - - -

Gross Profit

- 2.92 K - - - - - - - - -

Operating Income

-69.5 M -90.9 M -80.2 M - - - - - - - -

Interest Expense

2.7 M 1.91 M 300 K - - - - - - - -

EBITDA

-64.2 M -85.4 M -77.4 M -44.7 M - - - - - - -

Operating Expenses

92.5 M 93.8 M 80.5 M 46.4 M - - - - - - -

General and Administrative Expenses

27.6 M 19.9 M 21 M 9.9 M - - - - - - -

All numbers in USD currency

Quarterly Income Statement Codiak BioSciences

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- 25.2 M - 22.4 M 22.4 M 22.3 M 22.1 M 20.3 M 18.8 M 3.02 M 3 M 3 M 3 M 3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- -19.3 M -6.78 M -8.03 M - -21.7 M -21.8 M -10.3 M - -35.3 M -15.9 M -22.5 M - -20.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- 522 K - 12.7 M - 1.16 M 890 K 13.2 M - 954 K 187 K 134 K - 151 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- -21.4 M - -8.25 M - -21.5 M -21.5 M -9.95 M - -35 M -15.8 M -22.5 M - -21.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- 758 K - 600 K - 689 K 704 K 698 K - 607 K 294 K 295 K - 3 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- -18.2 M - -7.17 M - -17.3 M -20.1 M -8.56 M - -33.9 M -14.9 M -21.5 M - -20.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- 21.9 M - 21 M - 22.7 M 22.4 M 23.1 M - 36 M 16 M 22.6 M - 21.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- 6.56 M - 6.71 M - 7.19 M 6.94 M 6.59 M - 5.34 M 4.36 M 4.23 M - 4.84 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency